92 related articles for article (PubMed ID: 6728894)
1. [Enzymes as starting points for pharmaceutical development].
Wagner G
Pharmazie; 1984 Mar; 39(3):190-4. PubMed ID: 6728894
[No Abstract] [Full Text] [Related]
2. Thymidylate synthase inhibitors.
Ismail AS; Grem JL
Cancer Chemother Biol Response Modif; 2001; 19():1-19. PubMed ID: 11686010
[No Abstract] [Full Text] [Related]
3. Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family.
Ferrari S; Losasso V; Costi MP
ChemMedChem; 2008 Mar; 3(3):392-401. PubMed ID: 18270995
[No Abstract] [Full Text] [Related]
4. Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT).
Springer CJ; Bavetsias V; Jackman AL; Boyle FT; Marshall D; Pedley RB; Bisset GM
Anticancer Drug Des; 1996 Dec; 11(8):625-36. PubMed ID: 9022750
[TBL] [Abstract][Full Text] [Related]
5. Future challenges in the clinical development of thymidylate synthase inhibitor compounds.
Brandt DS; Chu E
Oncol Res; 1997; 9(8):403-10. PubMed ID: 9436193
[TBL] [Abstract][Full Text] [Related]
6. Thymidyl biosynthesis enzymes as antibiotic targets.
Chernyshev A; Fleischmann T; Kohen A
Appl Microbiol Biotechnol; 2007 Feb; 74(2):282-9. PubMed ID: 17216455
[TBL] [Abstract][Full Text] [Related]
7. [The biochemical basis of pharmaceutical chemistry. 10. Enzymes and enzyme inhibitors as drugs].
Nuhn P; Köhler T
Pharmazie; 1991 May; 46(5):365-82. PubMed ID: 1896484
[No Abstract] [Full Text] [Related]
8. Thymidylate synthase inhibitors.
Takimoto CH; Diggikar S
Cancer Chemother Biol Response Modif; 2005; 22():1-18. PubMed ID: 16110605
[No Abstract] [Full Text] [Related]
9. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
Chu E; Callender MA; Farrell MP; Schmitz JC
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
[TBL] [Abstract][Full Text] [Related]
10. [Critical remarks on trimethoprim/sulfonamide combinations in veterinary medicine].
Löscher W
Dtsch Tierarztl Wochenschr; 1984 Apr; 91(4):135-9. PubMed ID: 6376046
[No Abstract] [Full Text] [Related]
11. Thymidylate synthase inhibitors.
Touroutoglou N; Pazdur R
Clin Cancer Res; 1996 Feb; 2(2):227-43. PubMed ID: 9816165
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase inhibitors.
Ackland SP; Clarke SJ; Beale P; Peters GJ
Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
[No Abstract] [Full Text] [Related]
13. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
Papamichael D
Oncologist; 1999; 4(6):478-87. PubMed ID: 10631692
[TBL] [Abstract][Full Text] [Related]
14. Sulfamide antifolates inhibiting thymidylate synthase: synthesis, enzyme inhibition and cytotoxicity.
Pawełczak K; Makowski M; Kempny M; Dzik JM; Gołos B; Rode W; Rzeszotarska B
Acta Biochim Pol; 2002; 49(2):407-20. PubMed ID: 12362982
[TBL] [Abstract][Full Text] [Related]
15. Cell death in response to antimetabolites directed at thymidylate synthase.
Barbour KW; Berger FG
Cancer Chemother Pharmacol; 2008 Feb; 61(2):189-201. PubMed ID: 17396263
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and toxicological evaluation of a new series of thymidylate synthase inhibitors as anticancer agents.
Benassi L; Magnoni C; Giudice S; Bertazzoni G; Costi MP; Rinaldi M; Venturelli A; Coppi A; Rossi T
Anticancer Res; 2006; 26(5A):3499-504. PubMed ID: 17094473
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase inhibitors in colorectal cancer.
Cassidy J
Semin Oncol; 2000 Oct; 27(5 Suppl 10):83-7. PubMed ID: 11049037
[No Abstract] [Full Text] [Related]
18. [Determination of the rate constants for the interaction of enzymes with substrates and inhibitors during a short incubation time].
Brestkin AP; Maĭzel' EB
Vopr Med Khim; 1975; 21(2):125-8. PubMed ID: 1138496
[TBL] [Abstract][Full Text] [Related]
19. Benzoyl ring halogenated classical 2-amino-6-methyl-3,4-dihydro-4-oxo-5-substituted thiobenzoyl-7H-pyrrolo[2,3-d]pyrimidine antifolates as inhibitors of thymidylate synthase and as antitumor agents.
Gangjee A; Jain HD; McGuire JJ; Kisliuk RL
J Med Chem; 2004 Dec; 47(27):6730-9. PubMed ID: 15615522
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of potent thymidylate synthase X inhibitors.
Esra Onen F; Boum Y; Jacquement C; Spanedda MV; Jaber N; Scherman D; Myllykallio H; Herscovici J
Bioorg Med Chem Lett; 2008 Jun; 18(12):3628-31. PubMed ID: 18513963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
